Skip to main navigation Skip to search Skip to main content

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia

  • CLL17 Trial Investigators
  • University of Cologne
  • University Hospital Vall d'Hebron
  • Norwegian University of Science and Technology
  • Vita-Salute San Raffaele University
  • Ospedale San Raffaele and Vita-Salute San Raffaele University
  • Kantonsspital Luzern
  • University of Amsterdam
  • Helsinki University Hospital
  • Uppsala University
  • University of Copenhagen
  • Medical University of Vienna
  • Saarland University
  • Technion-Israel Institute of Technology
  • Royal College of Surgeons in Ireland
  • Ludwig Maximilian University of Munich
  • KU Leuven
  • Hanusch Krankenhaus
  • Innsbruck Medical University
  • Sjællands Universitetshospital
  • University of Turku
  • University of Rostock
  • University Hospitals Limerick
  • Sheba Medical Center at Tel Hashomer
  • Niguarda Hospital
  • University of Perugia
  • Martini Ziekenhuis
  • Albert Schweitzer Ziekenhuis
  • Ziekenhuis St Jansdal
  • Amphia Hospital
  • University of Oslo
  • Hospital Universitario 12 de Octubre
  • Hospital Universitario de la Princesa
  • Lund University
  • Linköping University
  • Cantonal Hospital St. Gallen
  • Kiel University
  • Ulm University

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science